The concentrations of markers of bone turnover in normal pregnancy and preeclampsia

Hypertension in Pregnancy

Volumn 31, Issue 1, 2012, Pages 166-176

  Dorota, Darmochwal Kolarz ^a   Bogdan, Kolarz G ^a   Mieczyslaw, Gorzelak ^a   Bozena, Leszczynska Gorzelak ^a   Jan, Oleszczuk ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

CrossLaps; Osteocalcin; Osteoprotegrin; Preeclampsia; Pregnancy; SRANKL

Indexed keywords

BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR;

ADULT; ARTICLE; BONE METABOLISM; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; OSSIFICATION; OSTEOLYSIS; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; BONE AND BONES; CASE-CONTROL STUDIES; COLLAGEN; FEMALE; HUMANS; OSTEOCALCIN; OSTEOPROTEGERIN; PEPTIDE FRAGMENTS; PRE-ECLAMPSIA; PREGNANCY; RANK LIGAND; YOUNG ADULT;

EID: 84455189066     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2010.484084     Document Type: Article

References (39)

1. Namgung R, Tsang RC. Bone in the pregnant mother and newborn at birth. Clin Chim Acta 2003; 333(1):1-11. (Pubitemid 36694822)
2. Ulrich U, Miller PB, Eyre DR, Chesnut CH, Schlebusch H, Soules MR. Bone remodeling and bone mineral density during pregnancy. Arch Gynecol Obstet 2003; 268(4):309-316 (Pubitemid 37210337)
3. Sanchez-Ramos L, Sandroni S, Andres FL, Kaunitz AM. Calcium excretion in preeclampsia. Obstet Gynecol 1991; 77:510-514.
4. Sanchez-Ramos L, Jones DC, Cullen MT. Urinary calcium as an early marker of preeclampsia. Obstet Gynecol 1991; 77:685-690.
5. Graves SW, Wood RJ, Brown EM, Seely EW. Calcium and calciotropic hormones in transient hypertension of pregnancy versus pre-eclampsia. Hypertens Pregnancy 1994; 13:87-95. (Pubitemid 24144727)
6. Belizan JM, Villar J, Gonzales L, Campodonico L, Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991; 325:1399-1404.
7. Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol 1995; 22:781-791.
8. Taufield PA, Ales KL, Resnick LM, Druzin ML, Gertner JM, Laragh JH. Hypocalciuria in preeclampsia. N Engl J Med 1987; 316:715-718. (Pubitemid 17044403)
9. Frenkel Y, Barkai G, Mashiach S, Dolev E, Zimlichman R, Weiss M. Hypocalciuria of preeclampsia is independent of parathyroid hormone level. Obstet Gynecol 1991; 77:689-691.
10. Wang W, Xu S, Zan Z. The relation of parathyroid function to pregnancy-induced hypertension. Chin Med J 1995; 108:576-578.
11. Lalau JD, Jans I, el Esper N, Bouillon R, Fournier A. Calcium metabolism, plasma parathyroid hormone, and calcitriol in transient hypertension of pregnancy. Am J Hypertens 1993; 6:522-527. (Pubitemid 23179500)
12. Li LM. Calcium metabolism in normal pregnancy and pregnancy induced hypertension. Chung Hua Fu Chan Ko Tsa Chih 1993; 28:389-391.
13. Frlich A, Rudnicki M., Storm T, Rasmussen N, Hegedüs L. Impaired 1,25-dihydroxyvitamin D production in pregnancy-induced hypertension. Eur J Obstet Gynecol Reprod Biol 1992; 47:25-29.
14. Siddiqui JA, Rana IA. Mineral and parathyroid hormone inter-relationships in normal pregnancy and pregnancy-induced hypertension. J Pak Med Assoc 1993; 43:92-95.
15. Gao S, Liu G, Li L. Observation and analysis on metabolism of serum calcium and phosphorus in patients with pregnancy-induced hypertension. Chung Hua Liu Hsing Ping Hsueh Tsa Chih 1998; 9:350-352.
16. Leibbrandt A, Penninger JM. RANK/RANKL: Regulators of immune responses and bone physiology. Ann N Y Acad Sci 2008; 1143:123-150.
17. Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-Kappa B ligand and osteoprotegrin in bone cell biology. J Mol Med 2001; 79:243-253. (Pubitemid 32646379)
18. Theill LE, Bovie WJ, Penninger JM. RANK-L and RANK: T cells, bone loss and mammalian evolution. Annu Rev Immunol 2002; 20:795-823. (Pubitemid 34293440)
19. Jones DH, Kong YY, Penninger JM. Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis 2002; 61:32-39.
20. Naylor KE, Rogers A, Fraser RB, Hall V, Eastell R, Blumsohn A. Serum osteoprotegrin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. J Clin Endocrin Metabol 2003; 88(11):5361-5365. (Pubitemid 37452739)
21. Uemura H, Yasui T, Kiyokawa M, et al. Serum osteoprotegrin/ osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. J Endocrinol 2002; 174(2):353-359. (Pubitemid 34965775)
22. Power MJ, Fottrell PF. Osteocalcin: Diagnostic methods and clinical applications. Crit Rev Clin Lab Sci 1991; 28(4):287-335.
23. Mori M. Beta-crosslaps. Nippon Rinsho 2004; 62(12):247-249.
24. National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1991; 165(1):236-237.
25. Black AJ, Topping J, Farquharson R, Fraser WD. Bone metabolism in pregnancy: A review. Contemp Rev Obstet Gynaecol 1996; 8:192-196. (Pubitemid 27116476)
26. Shahtaheri SM, Aaron JE, Johnson DR, Purdie DW. Changes in trabecular bone architecture in women during pregnancy. Br J Obstet Gynaecol 1999; 106:432-438. (Pubitemid 29201523)
27. Purdie DW, Aaron JE, Selby PL. Bone histology and mineral homeostasis in human pregnancy. Br J Obstet Gynaecol 1998; 95:849-854.
28. Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD. A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res 2000; 15:557-563. (Pubitemid 30134101)
29. Yasumizu T, Kato J. Concentrations of serum markers of type I collagen synthesis and degradation and serum osteocalcin in maternal and umbilical circulation. Endocr J 1996; 43:191-195. (Pubitemid 26161629)
30. Ainy E, Ghazi AA, Azizi F. Changes in calcium, 25(OH) vitamin D3 and other biochemical factors during pregnancy. J Endocrinol Invest 2006; 29(4):303-307. (Pubitemid 43905319)
31. Hong JS, Santolaya-Forgas J, Romero R, et al. Maternal plasma osteoprotegrin concentrations in normal pregnancy. Am J Obstet Gynecol 2005; 193(3):1011-1015. (Pubitemid 41285486)
32. Briana DD, Boutsikou M, Baka S, Hassiakos D, Gourgiotis D, Malamitsi-Puchner A. Circulating osteoprotegrin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction. Neonatology 2009; 96(2):2009.
33. Briana DD, Gourgiotis D, Boutsikou M, et al. Perinatal bone in term pregnancies: The influence of intrauterine growth restriction. Bone 2008; 42(2):307-313.
34. Seely EW, Wood RJ, Brown EM, Graves SW. Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. J Clin Endocrinol Metab 1992; 74:1436-1440.
35. Shaarawy M, Zaki S, Ramzi AM, Salem ME, El-Minavi AM. Feto-maternal bone remodeling in normal pregnancy and pre-eclampsia. J Soc Gynecol Invest 2005; 12(5):343-348. (Pubitemid 40848458)
36. Kumptepe Y, Aksoy H, Ingec M. Bone turnover in preeclamptic and normotensive pregnancy. Int J Obstet Gynecol 2005; 88(3):323-324. (Pubitemid 40283613)
37. Anim-Nyame N, Sooranna SR, Jones J, Alaghband-Zadeh J, Steer PJ, Johnson MR. Biochemical markers of maternal bone turnover are elevated in pre-eclampsia. BJOG 108 (3):258-262.
38. Anim-Nyame N, Sooranna SR, Jones J, Alaghband-Zadeh J, Steer PJ, Johnson MR. A longitudinal study of biochemical markers of bone turnover during normal pregnancy and pregnancies complicated by pre-eclampsia. BJOG 2002; 109(6):708-713. (Pubitemid 37329285)
39. Sowers M, Scholl T, Grewal J, Chen X, Jannausch M. IGF-I, osteocalcin and bone change in pregnant normotensive and pre-eclamptic women. J Clin Endocrin Metabol 2001; 86 (11):5898-5903. (Pubitemid 33152642)